Finance

Lists
STMN:SWX
Straumann Holding AG
CHF 95.74
+1.23%
(+1.16) 1D
Sep 21, 10:34:49 AM GMT+2  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for STMN...
Open
CHF 94.66
High
CHF 95.88
Low
CHF 94.40
Mkt. cap
15.27B
Avg. vol.
387.22K
Volume
28.87K
Dividend
1.04%
Quarterly dividend
CHF 0.25
Ex-dividend date
Apr 21, 2026
P/E ratio
41.29
52-wk high
CHF 109.80
52-wk low
CHF 73.02
EPS
CHF 2.32
Shares outstanding
159.46M
No. of employees
12K
Open
CHF 94.66
High
CHF 95.88
Low
CHF 94.40
Mkt. cap
15.27B
Avg. vol.
387.22K
Volume
28.87K
Dividend
1.04%
Quarterly dividend
CHF 0.25
Ex-dividend date
Apr 21, 2026
P/E ratio
41.29
52-wk high
CHF 109.80
52-wk low
CHF 73.02
EPS
CHF 2.32
Shares outstanding
159.46M
No. of employees
12K
News stories
From web sources and news partners
Profile
Straumann Group is a Swiss company based in Basel manufacturing dental implants and specialized in related technologies. The group researches, develops, manufactures and supplies dental implants, instruments, biomaterials, CADCAM prosthetics, digital equipment, software, and clear aligners for applications in replacement, restorative, orthodontic and preventative dentistry. The Straumann Group also offers services to the dental profession worldwide, including training and education, which is provided in collaboration with the International Team for Implantology and the Instituto Latino Americano de Pesquisa e Ensino Odontológico. Its products and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners. Wikipedia
About Straumann Holding AG
CEOGuillaume Daniellot | Guillaume Daniellot
Employees11.6K
Founded1954
HeadquartersBasel, Basel City, Switzerland
SectorMedical device
Website-
Last report
Aug 19, 2026
Fiscal period
Q2 2026
EPS / Est. (CHF)
CHF 1.64 / -
0.00%miss
Revenue / Est. (CHF)
1.38B / 698.90M
+97.38%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
9.50%
9.50%
18.10%
18.10%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps